Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor

By Wood M.D.   Boyfield I.   Nash D.J.   Jewitt F.R.   Avenell K.Y.   Riley G.J.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors

By Wicke K.   Garcia-Ladona J.  

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 85-90

Elsevier

Access to resources Recommend Favorite

The preferential dopamine D 3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain

By Scheideler M.A.   Martin J.   Hohlweg R.   Rasmussen J.S.   Naerum L.   Ludvigsen T.S.   Larsen P.J.   Korsgaard N.   Crider A.M.   Ghosh D.   Cruse S.F.   Fink-Jensen A.  

European Journal of Pharmacology, Vol. 339, Iss. 2, 1997-11 ,pp. : 261-270

Elsevier

Access to resources Recommend Favorite

Behavioral and neurochemical effects of the preferential dopamine D 3 receptor agonist cis-8-OH-PBZI

By Fink-Jensen A.   Nielsen E.B.   Hansen L.   Scheideler M.A.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 153-161

Elsevier

Access to resources Recommend Favorite

Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

By Keck Jr Paul E   McElroy Susan L  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 655-662

Informa Healthcare

Access to resources Recommend Favorite